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Abstract
Background: Linkage to HIV care is crucial to the success of antiretroviral therapy (ART) programs worldwide, loss
to follow up at all stages of the care continuum is frequent, and long-term prospective studies of care linkage are
currently lacking.
Methods: Consecutive clients who tested HIV-positive were enrolled from four HIV testing centers (1 health facility
and 3 community-based centers) in the Kilimanjaro region of Tanzania as part of the larger Coping with HIV/AIDS in
Tanzania (CHAT) prospective observational study. Biannual interviews were conducted over 3.5 years, assessing care
linkage, retention, and mental health. Bivariable and multivariate logistic regression analyses were conducted to
determine associations with early death (prior to the second follow up interview) and delayed (>6 months post-test)
or failed care linkage.
Results: A total of 263 participants were enrolled between November, 2008 and August, 2009 and 240 participants
not already linked to care were retained in the final dataset. By 6 months after enrollment, 169 (70.4 %) of 240
participants had presented to an HIV care and treatment facility; 41 (17.1 %) delayed more than 6 months, 15 (6.3 %)
died, and 15 (6.3 %) were lost to follow up. Twenty-six patients died before their second follow up visit and were
analyzed in the early death group (10.8 %). Just 15 (9.6 %) of those linked to care had started ART within 6 months, but
123 (89.1 %) of patients documented to be ART eligible by local guidelines had started ART by the end of 3.5 years. On
multivariate analysis, male gender (OR 1.72; 95 % CI 1.08, 2.75), testing due to illness (OR 1.63; 95 % CI 1.01, 2.63), and
higher mean depression scale scores (4 % increased risk per increase in depression score; 95 % CI 1 %, 8 %) were
associated with early death. Testing at a community versus a hospital-based site (OR 2.89; 95 % CI 1.79, 4.66) was
strongly associated with delaying or never entering care.
Conclusions: Nearly 30 % of the cohort did not have timely care linkage, ART initiation was frequently delayed, and
testing at a hospital outpatient department versus community-based testing centers was strongly associated with
successful care linkage.
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Background
A growing body of evidence has now demonstrated both
the therapeutic and preventative benefits of early anti-
retroviral therapy (ART), increasing the global urgency
to identify HIV-infected individuals and link them to
care [1–4]. However, programmatic, psychosocial, socio-
demographic, and illness-related barriers contribute to
substantial attrition across the care continuum [5–7].
Poor care linkage appears to be particularly pronounced
in sub-Saharan Africa, the world region most heavily af-
fected by the global HIV epidemic [6], and available lit-
erature suggests that most care attrition occurs even
before ART initiation occurs, contributing to the World
Health Organization’s recent recommendations to offer
immediate treatment to all HIV-positive persons world-
wide [5, 6, 8–10].
Despite the urgency to improve rapid entry into HIV
care and treatment for HIV-positive testers, there are
some key gaps in care linkage and retention data from
Africa, with most studies focusing on short time periods,
single facilities, or retrospective regional data that can-
not distinguish the care-seeking patterns of individual
patients [11–14]. Falsely low retention rates resulting
from patients moving between facilities was highlighted
by a Ugandan study, which demonstrated improvement
in estimated on-ART retention rates by 19 % after ac-
counting for patients who were receiving care at sites
other than their initial site of care linkage [15].
Delayed care entry has previously been associated with
higher CD4-positive T-lymphocyte cell count (CD4
count) [16]; sense of well-being, stigma, and transport
challenges [7]; male gender, and lack of family disclosure
[14, 17]. Care navigators who assist in escorting patients
through the care system have been associated with im-
proved linkage and retention [17, 18]. Mental illnesses
such as depression and post-traumatic stress disorder
(PTSD) have been increasingly demonstrated as factors
associated with lower levels of ART adherence in sub-
Saharan Africa [19], but have rarely been explored in the
context of care linkage [20]. The experience of traumatic
lifetime events has also been associated with poor reten-
tion in care in the U.S., while at the same time being
associated with earlier presentation to care [21].
Herein, we present a prospective study of participants
recruited from four different HIV testing centres in north-
ern Tanzania who were followed for 3.5 years with assess-
ments of psychosocial support, depressive and PTSD
symptomatology, and documentation of traumatic life-
time events. Our objective was to observe the trajectory
of care linkage over the course of the study and to de-
termine associations with care linkage that might ultim-
ately lead to policies to improve engagement after an
HIV-positive test. We hypothesized that depressive
symptoms, traumatic events, site of testing, and
sociodemographic characteristics such as income, age,
and gender, would be associated with care linkage. This
study is unique in its length of follow up, its recruit-
ment of participants from varied testing sites, and its
use of various measures of psychosocial and emotional
well-being to assess associations with care linkage and
retention, and therefore represents an important contri-
bution to the HIV care linkage literature.
Methods
Overview of study design
Coping with HIV/AIDS in Tanzania (CHAT) is a longi-
tudinal cohort study which took place between October,
2008 and April, 2013 with the primary aim of identifying
psychosocial factors (including potentially traumatic ex-
periences, depression, social support and sociodemo-
graphic factors) associated with adherence to HIV
therapy in a resource-limited setting after the roll-out of
antiretroviral therapy (ART). A total of 1188 participants
were enrolled through August of 2009, 263 of them after
having tested HIV-positive at participating HIV volun-
tary counselling and testing (VCT) centres; these partici-
pants (the VCT-positive cohort) are the focus of the
analyses in this manuscript. The full study sample size
was determined in order to discern differences between
participants who were and were not adherent to anti-
retroviral therapy [22]; the VCT cohort enrolled until the
expected number of 750 HIV-positive and a comparator
group of 200 HIV-negative individuals had been enrolled
into the study. STROBE guidelines were adhered to in
the planning and reporting of this research [23].
Study setting
Participants in the VCT-positive cohort were enrolled
from four HIV counselling and testing centres in Moshi
(population 184,292), the capital of the Kilimanjaro Re-
gion in Northern Tanzania (population 1.6 million; esti-
mated HIV seroprevalence 3.8 %) [24, 25]. Three of the
four testing centres were community-based VCT facil-
ities which offered walk-in HIV testing but no HIV treat-
ment services. The fourth testing centre was the
Kilimanjaro regional public hospital, which provides
walk-in HIV testing as well as provider initiated testing
and counselling for patients presenting to the hospital’s
outpatient department. The largest regional HIV Care
and Treatment Centre (CTC) is also located in the same
hospital complex. All persons who test HIV-positive in
Tanzania are provided with paper referrals to attend the
CTC of their choice. Patients who test positive at the re-
gional hospital and plan to establish care there may be
escorted to the on-site CTC if they wish. Throughout
the time of this study, there was a rapid expansion in
the number of CTCs in Kilimanjaro, ranging from rural
health centres to an urban private hospital [26].
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Participant selection and enrolment criteria
Clients aged 18–65 years who resided in three contigu-
ous districts of the Kilimanjaro Region and who tested
HIV-positive according to the standard Tanzanian HIV
testing algorithm were approached consecutively by
trained study staff and offered enrolment into the study.
Testers who planned to move outside the study area
were excluded.
Study instrument and follow up
The study was strictly observational and involved bian-
nual interviews by trained study staff. Participants who
had not presented to scheduled study visits were traced
by phone and in their homes or other contact locations
they had provided to the study staff. A targeted inter-
view surrounding date of death, symptoms prior to
death, and care-seeking at the end of life was conducted
with family members of participants who were reported
to have died. Data were entered onto secure netbook
computers using Entryware software. Surveys took place
at the regional hospital, at a nearby zonal referral hos-
pital, at a local non-governmental organization office in
Moshi, or at the participants’ homes. Demographic, fam-
ily, and relationship characteristics were assessed at each
round. Possession of one of the three items associated
with the highest quartile of weekly expenditures (a flush
toilet, indoor piped water, or a television) was utilized as
a measure of wealth for the purposes of this analysis.
At each visit, participants were asked whether they
had attended a CTC for their HIV-related care, which
CTC they attended, and about ART prescription and ad-
herence. Participants who reported that they had been
prescribed antiretroviral therapy were asked to select the
medications they had been prescribed using a picture
and word chart with commonly prescribed medications.
Those in VCT-positive cohort who enrolled into care at
the regional hospital or at the northern zonal hospital
were also followed by study staff with a biannual clinical
survey onto which data from the patients’ hospital charts
were extracted. For the last two rounds of surveys, all
participants were requested to bring their CTC cards to
the study visit. These cards are given to all HIV-positive
patients in Tanzania and visit dates, medication prescrip-
tions, World Health Organization HIV clinical stage, and
CD4 count results are recorded on them.
Overall performance and symptomatology was assessed
using the Physical Composite Score (PCS), calculated
from the short form (SF)-8, which has been validated in
Africa [27, 28]; a longer form has been utilized for assess-
ment of HIV-related symptomatology in other Africa co-
horts [29, 30]. Traumatic life events were measured using
the Life Events Checklist, the Childhood Trauma Ques-
tionnaire, and other items which assessed the experience
of adult and childhood physical and sexual abuse,
childhood neglect, experience of conflict or substance
abuse in the childhood home, loss of loved ones, and other
traumatic events; this has been previously described in de-
tail [31]. In order to assess for depressive severity, the
Personal Health Questionnaire (PHQ)-9, which has been
widely validated including in sub-Saharan Africa, was
administered [32–35]. Post-traumatic stress disorder
was ascertained using the PTSD Symptoms Checklist
(PCL) [36]. Stigma was measured in two domains utilizing
a scale validated in South Africa: attributed stigma, which
measured community-level norms; and internalized stigma,
which measured HIV-positive persons’ self-stigmatizing
beliefs [37]. Social support was measured using a 76-
point scale [38].
Study endpoints
The main goals of this analysis were to describe the
overall flow of participants as they engaged in care the
3.5 years of the study and to determine factors associ-
ated with failure to link to care within 6 months of an
HIV positive test. Participants who delayed entering HIV
care for more than 6 months after their diagnosis and
those who never entered care throughout the entire
3.5 years of the study were analysed together as one
group (delayed/failed care linkage). Care linkage was de-
fined as verbal report of clinic attendance at a recog-
nized Care and Treatment Centre (CTC), but efforts
were made to back up the report with concrete data in-
cluding National HIV Program Identification cards and
clinical records. It was noted that several participants
died before care linkage data became available and/or
presented to acute care for a life-threatening illness ra-
ther than presenting for routine HIV care. Therefore, pa-
tients who died early were analysed as a separate group.
We defined early death as any participant who died prior
to their second follow up interview as half of all deaths
throughout the 3.5 year follow up occurred during this
time frame. Participants who were lost to follow up with
no further contact after the baseline study interview
were included within the denominator but were not in-
cluded in the groups of individuals who were deceased
or delayed linkage to care. This was because it was im-
possible to determine whether such individuals had died,
never linked to care, or linked to care but did not return
for study visits. Determination of ART eligibility was
made utilizing available patient data from clinical case
report forms and CTC cards, and was based on the
Tanzanian National Guidelines [39]. Prior to 2009, the
guidelines recommended initiation of antiretroviral ther-
apy for patients with a CD4 count <200 cells/μL or
WHO Stage IV clinical illness. These guidelines were re-
vised in January 2009 to additionally recommend ART
initiation at <350 cells/μL if a WHO Stage III illness was
present. Participants with missing eligibility data who
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started ART were considered to have been eligible; pa-
tients missing eligibility who did not start ART were ex-
cluded from the denominator of eligible patients and
were recorded separately.
Data analysis
All analyses were conducted using Stata version 11.0
(Statacorp, College Station, TX, USA). Categorical
variables were first analysed using chi-square tests and
maximum-likelihood odds ratios. Continuous variables
were noted to have skewed distributions and therefore
were assessed by comparison of medians utilizing
Wilcoxon rank sum test. Because of the relatively small
dataset and bias inherent in stepwise models, a predeter-
mined number of factors (approximately 1 per 10
endpoints) thought based on available local and epide-
miologic data to be relevant to care linkage were se-
lected for use in a multivariate model. A biprobit
multivariable regression model was constructed to
explore factors associated with early death and delayed/
failed care linkage simultaneously within a joint model.
Use of a joint model allowed for determination of
possible overlap between the characteristics of the patients
who died early and those who delayed in linking to care.
Separate logistic models for each dependent variable were
created for comparison with the biprobit model.
Results
A total of 263 participants were enrolled between
November, 2008 and August, 2009 from four HIV testing
centres. Twenty-two patients had tested in order to re-
confirm a previously positive test, but were already in care
(on ART and/or clinic visit in the last 12 months). These
participants were excluded from analyses, as was one add-
itional participant who was missing all data, leaving 240
participants in the final dataset (Fig. 1). Baseline sociode-
mographic characteristics are displayed in Table 1. Most
participants were women (163 (67.9 %) of 240) and had
no education or primary education (209, 87.1 %). About
half resided in rural areas (123, 51.3 %) and 102 (42.5 %)
were married or cohabitating. Linkage to care data was
validated by at least one concrete source (CTC card or
chart review) for 160 (83.3 %) of the 192 who reported
attending clinic.
The majority of participants (149, 62.1 %) were enrolled
from the regional hospital outpatient department HIV
testing centre, with the remaining (91, 37.9 %) enrolled
from the three community VCT sites. By 6 months after
enrolment, 169 (70.4 %) of 240 participants reported pre-
senting to an HIV care and treatment facility; 41 (17.1 %)
delayed more than 6 months, 15 (6.3 %) died, and 15
(6.3 %) were lost to follow up with no further contact after
the baseline interview. Twenty-six patients died before
their second follow up visit and were analysed in the early
death group (10.8 %). Forty-one (17.1 %) participants had
not yet sought care at a CTC within 6 months of their
enrolment into the study; 27 (11.3 %) eventually linked to
care more than 6 months after enrolment, and 13 (5.5 %)
remained in the study but did not present to care through
3.5 years of follow up. Among those with available re-
sponses, feeling well was the most commonly reported
reason for delayed care entry (22 (67 %) of 33), followed
by fear of stigma/rejection by a partner (5 (15 %) of 33) or
others in the family or community (4 (12 %)).
Bivariable associations between care entry and socio-
demographics/testing characteristics (Table 1) and psy-
chosocial measures (Table 2) are displayed. Early death
was significantly associated with male gender (OR 3.34;
95 % CI 1.42, 7.81), being unemployed (OR 4.48; 95 %
CI 1.15, 17.49), testing due to illness (OR 3.07; 95 % CI
1.31, 7.21), and lower physical performance scores (me-
dian 39.3 vs. 42.5, p = 0.032). In addition, early death
was associated with significantly higher depressive
symptomatology (median score 10.7 vs. 9.0, p = 0.012) but
lower numbers of traumatic events during adult life
(median 0 vs. 1 event, p = 0.008). On multivariate analysis,
male gender (OR 1.72; 95 % CI 1.08, 2.75), testing due to
illness (OR 1.63; 95 % CI 1.01, 2.63) and higher depressive
symptomatology (a 4 % increased risk of early death for
each point of increase in PHQ-9 score; 95 % CI 1–8 %)
were associated with early death.
Delayed care linkage or never presenting to care was sig-
nificantly associated with testing at a community facility
(OR 6.84; 95 % CI 2.99, 15.64), younger age (median 32 vs.
36.5 years, p <0.001), secondary education (OR 2.84, 95 %
CI 1.20, 6.71), lower childhood trauma scores (p = 0.014),
and illness at the time of testing (negative association, OR
0.36, 95 % CI 0.16, 0.84) (Tables 1 and 2). On multivariate
analysis (Table 3), community testing site remained signifi-
cantly associated with delayed care linkage (OR 2.89; 95 %
CI 1.79, 4.66). Testing due to illness was also negatively as-
sociated with delayed care linkage (OR 0.58; 95 % CI 0.34,
0.96). Age retained borderline significance (2 % decrease in
risk of delayed or failed care linkage for each year increase
in age; 95 % CI 0–5 %).
A total of 169 patients (70.4 %) were retained in the
cohort for at least one follow up visit and reported
linkage to care within six months of their initial
HIV-positive test. Of these, 89 (57.1 %) participants had
documented CD4 cell count or other eligibility criteria
performed within 6 months of their initial positive test
and 67 (75.3 %) of those with CD4 cell count results
were eligible for ART (Fig. 2). However only 15 (22.3 %)
of those eligible by CD4 initiated ART within 6 months
of diagnosis. By 12 months after enrolment, just 4 add-
itional participants had linked to care, but the number
who had started ART increased to 63 (86.3 % of those
documented to be eligible). By the end of the 3.5 year study,
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192 participants had presented to care, and 123 (89.1 % of
those eligible and 64.0 % of the linked cohort) had started
ART. Among patients who reported linkage to care but
were never prescribed ART (n = 69), 26 (38 %) were not
eligible, 15 (22 %) were eligible but had not initiated ART,
11 (16 %) died prior to ART initiation, 10 (14 %) were lost
to study follow up prior to initiation of ART, and 7 (10 %)
were missing eligibility information. Participants who tested
HIV-positive at community testing sites were significantly
less likely to have ART eligibility data available (OR 0.52;
95 % CI 0.30, 0.90) and less likely to report initiation of
ART at any time during the study (OR 0.58; 95 % CI 0.34,
0.98) compared to those who tested HIV-positive at the re-
gional hospital outpatient department.
Discussion
In this prospective study of care linkage and retention
among a cohort of 240 participants enrolled from distinct
HIV counselling and testing sites in northern Tanzania,
30 % of patients were lost to study follow up or not in care
within six months of their HIV diagnosis, which is similar
to data previously described in sub-Saharan Africa in
cross-sectional or shorter term prospective studies [5, 6].
Importantly, the prime factor associated with care linkage
in our study in both bivariable and multivariate analyses
was testing site, with patients who tested HIV-positive at
community-based facilities more than twice as likely to
delay care linkage more than 6 months or to never link to
care throughout 3.5 years of study follow up. Similarly,
lower levels of ART assessment and ART initiation were
noted in the group of participants who enrolled from
community sites compared to those who enrolled at the
regional hospital outpatient department. This association
between community-based testing and delayed/failed care
linkage held even after adjusting for factors such as age,
gender and illness which might have distinguished those
who opted to test in the community from those who
tested at the hospital outpatient department. To our
knowledge, this has not been previously documented in
the literature as part of a prospective cohort study, and it
complements other studies in diverse environments which
demonstrate that co-location of testing and care services,
263 participants tested HIV-positive and enrolled
240 patients included in analyses
22 already attending clinic
1 missing all data
210 presented to at least 1 study follow up visit
15 died prior to any  
documented follow up
15 lost to study follow up*
192 linked to care
13 never linked to care†
3 incomplete care linkage 
data and subsequently lost to 
follow up
2 incomplete care linkage 
data and subsequently died
147 had CD4 and/or WHO Staging results
30 missing eligibility information**
123 started ART
26 not eligible for ART
7 not on ART, missing eligibility
5 died
10 lost to  study follow up
6 died
15 eligible but had not yet 
started antiretroviral therapy
(ART)
13 died (all post-ART start)
3 lost to study follow up (all 
post-ART start)
Fig. 1 Flow of participants enrolled from four HIV testing centres in Tanzania through 3.5 years of follow up. *Lost to study follow up is defined
as participants who no longer attended any study visits or missed their last 2 scheduled study visits. †Participants who followed at study visits
but reported never attending an HIV care and treatment center (CTC). **Eligibility for antiretroviral therapy (ART) determined according to local
guidelines at the time patients were being followed, described in methods
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and/or direct facilitation (care navigation) improve care
linkage and ART initiation [40–42]. Despite the fact that
the community testing sites in Moshi from which our
study participants were recruited were within a 2 km
radius of the regional hospital CTC, escorting the partici-
pant to CTC, as is often done for hospital outpatient de-
partment testers, appears to have additional value. It is
possible that people who test in healthcare environments
feel more comfortable accessing care, or that there are
other unmeasured differences between those who decide
to test at community-based versus health care based cen-
tres, however the strength of our association after adjust-
ing for other factors suggests that it is a key independent
factor in care linkage. It is also noteworthy that the great
Table 1 Baseline characteristics sociodemographic and testing characteristics of 240 participants enrolled from HIV counseling and
testing centers, and univariate associations with early deatha or late or no presentation to careb
Total Early death Late or no presentation to care
N or
median
% or
IQRc
N or
median
% or
IQR
ORc 95 % CI p N or
median
% or
IQR
OR 95 % CI p
Total 240 26 10.8 % 40 16.7 %
Gender
Female 163 67.9 % 11 6.7 % 1.00 27 16.6 % 1.00
Male 77 32.1 % 15 19.5 % 3.34 (1.42, 7.81) 0.003 13 16.9 % 0.98 (0.47, 2.02) 0.951
Age, years 36.5 (31, 43) 37.5 (31, 42) 0.772 32 (27, 37.5) <0.001
Enrollment site
Hospital OPDc, d 149 62.1 % 18 12.1 % 1.00 10 6.7 % 1.00
Community VCTc 91 37.9 % 8 8.8 % 0.70 (0.30, 1.69) 0.701 30 33.0 % 6.84 (2.99, 15.64) <0.001
Tested due to feeling sick
No 150 62.5 % 10 6.7 % 1.00 32 21.3 % 1.00
Yes 89 37.1 % 16 18.0 % 3.07 (1.31, 7.21) 0.007 8 9.0 % 0.36 (0.16, 0.84) 0.014
Marital status
Married or cohabitating 102 42.5 % 12 11.8 % 1.00 16 15.7 % 1.00
Widowed 35 14.6 % 4 11.4 % 0.97 (0.29, 3.23) 0.603 5 14.3 % 0.89 (0.30, 2.67) 0.895
Separated or divorced 60 25.0 % 7 11.7 % 0.99 (0.37, 2.68) 0.770 9 15.0 % 0.95 (0.39, 2.31) 0.907
Never married 43 17.9 % 3 7.0 % 0.56 (0.15, 2.12) 0.389 10 23.3 % 1.63 (0.76, 3.98) 0.280
Education
None or primary 209 87.1 % 22 10.5 % 1.00 30 14.4 % 1.00
Secondary or higher 31 12.9 % 4 12.9 % 1.25 (0.40, 3.94) 0.692 10 32.3 % 2.84 (1.20, 6.71) 0.013
Primary residence
Rural 123 51.3 % 13 10.6 % 1.00 1 21 17.1 % 1.00
Urban 114 47.5 % 10 8.8 % 0.81 (0.34, 1.94) 0.641 19 16.7 % 0.97 (0.49, 1.92) 0.934
Primary occupation
Business 76 31.7 % 7 9.2 % 1.00 13 17.1 % 1.00
Farming 39 16.3 % 5 12.8 % 1.45 (0.42, 4.94) 0.551 7 17.9 % 1.06 (0.38, 2.93) 0.910
Non-professional worker
(e.g., cleaning)
87 36.3 % 5 5.7 % 0.60 (0.18, 1.99) 0.400 12 13.8 % 0.77 (0.33, 1.83) 0.559
Professional (e.g., nurse) 22 9.2 % 4 18.2 % 2.19 (0.56, 8.44) 0.243 4 18.2 % 1.42 (0.44, 4.59) 0.551
Unemployed 16 6.7 % 5 31.3 % 4.48 (1.15, 17.49) 0.018 4 25.0 % 1.62 (0.44, 5.87) 0.462
3 item wealth asset scale
0 items 119 49.6 % 10 8.4 % 1.00 17 14.3 % 1.00
1–3 items 121 50.4 % 16 13.2 % 1.66 (0.72, 3.84) 0.231 23 19.0 % 1.40 (0.71, 2.80) 0.327
aDeath prior to 2nd study follow up visit
bPresented to clinic >6 months after HIV+ diagnosis, or no presentation to clinic
cAbbreviations: OR odds ratio, IQR intraquartile range, OPD outpatient department, VCT voluntary counseling and testing
dIncludes both clients who presented specifically requesting an HIV test, and clients tested as part of provider initiated testing and counseling during an
outpatient visit
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majority of patients who linked to care throughout the
study did so within 6 months of their positive test; there-
fore, that early period is critical in establishing care prac-
tices over the coming years.
As is the case with many other care linkage studies in
Africa, our data reveal gaps not just in patient presentation
to care, but in assessment of ART eligibility and initiation
of ART [12–14]. This was particularly the case early on in
the study, with only about 10 % of participants who linked
to care initiating ART within 6 months. Nonetheless these
proportions increased steadily throughout the study such
that nearly 90 % of participants with documented eligibility
had initiated ART by the end of the study. Potential adop-
tion of new international guidelines to initiate all patients
on ART regardless of CD4 cell count may have major bene-
fits in reducing such delays.
As evidenced by the early mortality in this and all linkage
to care studies in sub-Saharan Africa, immediate care
entry and ART initiation may have lifesaving potential.
Additionally, a consistent community and healthcare policy
message that all people with HIV should start ART might
assist in curbing the dangerous belief that there is no need
to present to testing and/or care until one is ill. This belief
was pervasive among our study participants who delayed
care, and may also have been present among those who
died within six months of enrolment, significantly more of
whom tested due to illness. A recent qualitative study iden-
tified many of these concerns among Kenyans living with
HIV; one theme that emerged was patients’ belief that ART
was something only necessary during dire illness [43].
Increased severity of depressive symptoms was signifi-
cantly and independently associated with early death,
but not with late linkage to care. Early death may have
been a surrogate for testing late in the course of illness,
and it is possible that testing late in the course of illness
may have been associated with depression. In addition,
despite its independent association with early death
on multivariate analysis, given the lower physical
Table 2 Associations between psychosocial factors and early deatha or late or no presentation to careb among 240 participants
enrolled from HIV counselling and testing centres
Total sample Early death Late or no presentation to care
Mean Median Mean Median p* Mean Median p*
SF-8 physical (0–100)c 44.2 46.3 39.3 42.5 0.032 44.7 46.4 0.579
PHQ-9 (0–27)c 7.6 7.0 10.7 9.0 0.012 7.6 7.0 0.732
PTSD (0–68)c 11.1 9.0 9.0 6.5 0.103 11.5 7.0 0.325
Stigma, attributed (0–12) 6.2 7.0 6.0 5.5 0.889 6.5 7.0 0.651
Stigma, internalized (0–44) 18.3 16.0 17.0 17.6 0.879 16.6 16.0 0.803
Support (0–76) 43.7 43.0 47.4 49.5 0.285 43.2 44.0 0.833
Childhood trauma index (0–13)d 1.8 2.0 1.5 1.0 0.226 1.8 2.0 0.014
Adult trauma index (0–5)d 0.79 1.0 0.4 0.0 0.008 0.9 1.0 0.341
*Compares results of psychosocial/stigma scales for participants with early death to the total sample, and participants with late presentation to care to the total
sample. Those with early death were not compared directly to those with late/no care presentation
aDeath prior to 2nd study follow up visit
bPresented to clinic >6 months after HIV+ diagnosis, or no presentation to clinic
cAbbreviations: SF8 8 question short from of the of physical performance scale–see manuscript text for details, higher scores indicate higher functioning, PHQ-9
personal health quesionnaire-9, assesses depression, higher scores indicate higher depression levels, PTSD post-traumatic stress disorder, higher scores indicate
higher levels of PTSD symptoms
dChildhood and adult trauma index correspond to the number of study-assessed traumatic events that occurred in childhood or adulthood
Table 3 Multivariate analysis of associations with early deatha or late or no presentation to careb among 237c participants enrolled
from HIV counselling and testing centres
Early death Late or no presentation to care
OR 95 % CI p OR 95 % CI p
Male gender 1.72 (1.08, 2.75) 0.022 1.15 (0.73, 1.83) 0.540
Age 0.99 (0.96, 1.02) 0.566 0.98 (0.95, 1.00) 0.057
Community enrollment site 0.76 (0.44, 1.30) 0.257 2.89 (1.79, 4.66) <0.0001
Tested due to illness 1.63 (1.01, 2.63) 0.044 0.58 (0.34, 0.96) 0.034
PHQ-9 1.04 (1.01, 1.08) 0.012 0.99 (0.96, 1.03) 0.680
Stigma, internalized 1.00 (0.93, 1.04) 0.551 0.98 (0.93, 1.03) 0.368
Abbreviations: OR odds ratio, CI confidence interval, PHQ-9 personal health quesionnaire-9 (assesses depression, higher scores indicate higher depression levels)
adeath prior to 2nd study follow up visit
bpresented to clinic >6 months after HIV+ diagnosis, or no presentation to clinic
cparticipants with missing data in any measure were excluded
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performance scores and association with testing due to
illness in the early death group, depression in this group
may have been a result of physical illness.
Surprisingly, most of the other mental health and psy-
chosocial measures explored as predictors of care linkage
and retention showed no significant association in this
study. Several factors may have contributed to this finding.
Baseline interviews sometimes took place on the day of
testing and other times up to a few weeks after the posi-
tive test. This variation in and of itself could have im-
pacted responses to sensitive items such as stigma,
depression and PTSD, thereby biasing effects estimates. In
our study, traumatic events were associated with better
linkage to care. This is consistent with data from the U.S.
which found that childhood trauma increased health-
seeking behaviour [21].
The finding that men were more likely to experience
early death in this study reflect findings from other sub-
Saharan African studies which demonstrate that men are
often more difficult to engage for testing [44, 45], more
likely to delay care linkage [14, 17], and more likely to
drop out of care [46]. Further research is needed to under-
stand the unique concerns of men and to adapt appropri-
ate linkage and retention efforts targeted towards them.
This study has several important strengths, including
the long length of follow up, the comprehensive nature
of the survey instrument, and the recruitment of partici-
pants from several different HIV testing sites. Several
weaknesses are also important to note. Linkage to care
was documented in patients who followed in study-
affiliated clinics or who presented with their CTC card,
but was reported only verbally in 17 % of cases and may
have been subject to social desirability bias. Nonetheless,
very detailed questions were asked about site of care
linkage, names of ART medications, etc., helping to val-
idate the responses that were received. The relatively
small numbers patients who had died or failed/delayed
care linkage limited the power of the study to distinguish
the unique characteristics of each of these groups, which
may be quite important in further delineating risks for
poor follow up and measures to improve it. Information
about clients who opted to participate in the study ver-
sus those who declined participation is not available; se-
lection bias may have incurred for patients enrolled
were actually more likely to follow up and therefore esti-
mates provided may be overestimates of actual levels of
follow up. Finally, given the similarity of themes identi-
fied in this study compared to other sub-Saharan African
settings, we believe that these results are generalizable to
other sub-Saharan African settings with similar set-ups
(HIV testing offered in various different locales without
mandatory patient navigation).
Conclusions
Our prospective 3.5 year study demonstrated that testing
site strongly impacted linkage to care in Tanzania, with
testers at community based sites more likely to delay or
fail to present for care than those who tested at the
Fig. 2 Cascade of care entry, CD4 testing and antiretroviral therapy (ART) initiation at 6, 12, and 42 months among 240 patients who tested HIV-positive
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hospital outpatient clinic. Targeting linkage efforts to-
wards community-based centres and co-locating HIV test-
ing and care should be an urgent public health priority. In
addition, marked delays in initiation of ART were evident
even among patients who linked to care quickly after diag-
nosis. We hope that our results strengthen movements to
co-locate testing and treatment, to offer navigation ser-
vices, and to expand immediate provision of ART.
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